Overview

A QT/QTc Evaluation Study of TS-172 in Healthy Adult Subjects

Status:
COMPLETED
Trial end date:
2025-05-26
Target enrollment:
Participant gender:
Summary
A clinical study to evaluate the effects on QT/QTc interval of TS-172 in healthy adults subjects
Phase:
PHASE1
Details
Lead Sponsor:
Taisho Pharmaceutical Co., Ltd.
Treatments:
Moxifloxacin